Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
Top Cited Papers
- 1 April 2010
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 9 (4) , 438-446
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Progressive Multifocal Leukoencephalopathy after Natalizumab MonotherapyNew England Journal of Medicine, 2009
- Treatment of Progressive Multifocal Leukoencephalopathy Associated with NatalizumabNew England Journal of Medicine, 2009
- Reemergence of PML in Natalizumab-Treated Patients — New Cases, Same ConcernsNew England Journal of Medicine, 2009
- Opportunistic infections and other risks with newer multiple sclerosis therapiesAnnals of Neurology, 2009
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) studyThe Lancet Neurology, 2009
- Evaluation of Patients Treated with Natalizumab for Progressive Multifocal LeukoencephalopathyNew England Journal of Medicine, 2006
- Progressive Multifocal Leukoencephalopathy in a Patient Treated with NatalizumabNew England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple SclerosisNew England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's DiseaseNew England Journal of Medicine, 2005
- Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluidJournal of Virological Methods, 2004